Track CymaBay Therapeutics, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

CymaBay Therapeutics, Inc. CBAY · Stock Open CymaBay Therapeutics, Inc. in new tab

32.48 USD
Add to portfolio
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...

DCF Valuation

Tweak assumptions to recompute fair value for CymaBay Therapeutics, Inc. (CBAY)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

CymaBay Therapeutics, Inc. Logo CymaBay Therapeutics, Inc. Analysis (CBAY)

United States Health Care Official Website Stock

Is CymaBay Therapeutics, Inc. a good investment? CymaBay Therapeutics, Inc. (CBAY) is currently trading at 32.48 USD.

Investor FAQ

Does CymaBay Therapeutics, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is CymaBay Therapeutics, Inc.?

CymaBay Therapeutics, Inc. is classified as a Stock. You can compare it against 4 other assets in the "Related Symbols" list on this page.

Company Profile

No detailed summary available for CymaBay Therapeutics, Inc..

Exchange Ticker
FRA (Germany) C0I.F
STU (Germany) C0I.SG
LSE (United Kingdom) 0I5P.L
NMS (United States) CBAY
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion